First-in-human imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumors of the lung and prostate
Salomon Tendler, Mark P. Dunphy, Matthew Agee, Joseph O’Donoghue, Rania G. Aly, Noura J. Choudhury, Adam Kesner, Assen Kirov, Audrey Mauguen, Marina K. Baine, Heiko Schoder, Wolfgang A Weber, Natasha Rekhtman, Serge K. Lyashchenko, Lisa Bodei, Michael J. Morris, Jason S. Lewis, Charles M. Rudin, John T. Poirier
medRxiv 2024.01.10.24301109; doi: https://doi.org/10.1101/2024.01.10.24301109